Clinical trial

DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics

NCT00752960

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2007-01-01

PhaseN/A

Study timeline

Study start (unknown)2007-01-01Date precision: month

Registry last updated2008-09-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Psychosesunresolved

Interventions

Sponsors & collaborators

Genomas, Inclead sponsor

Hartford Hospitalcollaborator

University of Kentuckycollaborator

Mapped research locations

LexingtonKentucky, United States1 HartfordConnecticut, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00752960 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.